Uso medicinal de la marihuana: la discusión pendiente - Réplica

Martín Nizama-Valladolid

Resumen


Uso medicinal de la marihuana: la discusiónpendiente - Réplica

Texto completo:

PDF

Referencias


DeJesus E, Rodwick BM, Bowers D, Cohen CJ, Pearce D. Use of dronabinol improves appetite and reverses weight loss in HIV/ AIDS-infected patients. J Int Assoc Physicians AIDS Care (Chic). 2007;6(2):95-100.

Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;371(9):879.

Hancox RJ, Shin HH, Gray AR, Poulton R, Sears MR. Effects of quitting cannabis on respiratory symptoms. Eur Respir J. 2015;46(1):80-7.

Food and Drug Administration [Internet]. Hampton, Virginia: FDA; c2017 [citado el 14 de febrero de 2017]. Disponible en: https://www.fda.gov/

Levin FR, Mariani JJ, Pavlicova M, Brooks D, Glass A, Mahony A, et al. Dronabinol and lofexidine for cannabis use disorder: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. 2016;159:53-60.

Häuser W1, Fitzcharles MA, Radbruch L, Petzke F. Cannabinoids in Pain Management and Palliative Medicine. Dtsch Arztebl Int. 2017;114(38):627-34.

Häuser W, Petzke F, Fitzcharles MA. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews. 2017 Oct 15. doi: 10.1002/ ejp.1118. [Epub ahead of print]

Mack A, Joy J. Marijuana as Medicine? The Science Beyond the Controversy. Washington, DC: National Academies Press; 2000.


Enlaces refback

  • No hay ningún enlace refback.